TOTH FINANCIAL ADVISORY CORP
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 866780
LEESBURG, VA
Position in VRTX
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$136,641
+$32,369 QoQ
Shares Held
306
+33.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98.0392156862745.ToString("F0")%
Shared 0.ToString("F0")%
None 1.9607843137254901.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TOTH FINANCIAL ADVISORY CORP holds $6,027,293 across 24 Biotechnology names. VRTX ranks #6 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
13,695 | $1,288,973 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
6,600 | $1,247,730 | |
| 3 | ASND |
Ascendis Pharma A/S
|
5,450 | $1,246,578 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,000 | $1,046,940 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
10,000 | $869,700 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
306 | $136,641 | |
| 7 | ARGX |
Argenx SE
|
145 | $105,886 | |
| 8 | EYPT |
EyePoint, Inc.
|
2,001 | $25,792 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $136,641 | 306 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $104,272 | 230 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $90,077 | 230 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $102,396 | 230 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $111,508 | 230 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $92,621 | 230 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $720,874 | 1,550 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $46,872 | 100 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $41,801 | 100 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $40,689 | 100 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $34,774 | 100 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $35,191 | 100 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $43,794 | 139 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $28,878 | 100 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $28,954 | 100 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $28,179 | 100 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $26,097 | 100 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $21,960 | 100 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $3,265 | 18 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $3,629 | 18 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $3,868 | 18 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $4,254 | 18 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $787,243 | 2,893 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $1,307,265 | 4,503 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $966,077 | 4,060 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||